For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
Vol. 32, No. 1, Proceedings of the 1982 I.O.S. Annual Conference on Practical Bayesian Statistics (Mar. - Jun., 1983), pp. 118-123 (6 pages) The Statistician joined the Journal of the Royal ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
Journal of the Royal Statistical Society. Series D (The Statistician), Vol. 36, No. 2/3, Special Issue: Practical Bayesian Statistics (1987), pp. 289-296 (8 pages) This paper presents preliminary ...
ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
In today’s ACT Brief, we examine what will separate sponsors that scale AI beyond pilots in 2026, break down the FDA’s new ...
This course covers the ideas underlying statistical modelling in science through the lens of causal thinking. We cover the implementation of these ideas through Bayesian computational methods and ...
Articulate the primary interpretations of probability theory and the role these interpretations play in Bayesian inference Use Bayesian inference to solve real-world statistics and data science ...
Bayesian quantile regression and statistical modelling represent a growing paradigm in contemporary data analysis, extending conventional regression by estimating various conditional quantiles rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results